DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC

Institutional investor · Portfolio as of Q1 2021

Top Holdings435 positions

Checking export access…
Activity:
TSMTSM
ADR

TAIWAN SEMICONDUCTOR MANUFAC

3M$350.3M5.2%$38.06+184.63%
9 qtrssince 2019-Q1
Decreased
0
BABABABA
ADR

ALIBABA GROUP HLDG LTD

630,016$142.8M2.1%$182.58+19.24%
9 qtrssince 2019-Q1
Decreased
0
HDBHDB
ADR

HDFC BANK LTD

1.5M$113.3M1.7%$25.95+39.04%
9 qtrssince 2019-Q1
Decreased
0
IBNIBN
ADR

ICICI BK LTD

6.1M$97.7M1.4%$11.47+35.10%
9 qtrssince 2019-Q1
Increased
52

EPAM SYS INC

237,005$94M1.4%$337.68+13.57%
9 qtrssince 2019-Q1
Increased
56
SWTXSWTXAcquired

SPRINGWORKS THERAPEUTICS INC

1.3M$92.9M1.4%——
7 qtrssince 2019-Q3
Increased
51

VISA INC

422,981$89.6M1.3%$207.17-1.88%
2 qtrssince 2020-Q4
Increased
69

RELAY THERAPEUTICS INC

2.5M$87.9M1.3%$37.51-5.15%
3 qtrssince 2020-Q3
Increased
76

NATERA INC

771,185$78.3M1.2%$32.51+212.29%
8 qtrssince 2019-Q2
Decreased
0
BIDUBIDU
ADR

BAIDU INC

352,806$76.8M1.1%$218.230.00%
1 qtr
New
68

MICRON TECHNOLOGY INC

855,536$75.5M1.1%$74.51+13.32%
2 qtrssince 2020-Q4
Increased
63

CYTOKINETICS INC

3.2M$75.3M1.1%$12.27+82.02%
8 qtrssince 2019-Q2
Increased
47

ULTRA CLEAN HLDGS INC

1.3M$74.7M1.1%$34.22+69.60%
6 qtrssince 2019-Q4
Increased
64
NVTAQNVTAQDelisted

Invitae Corp

1.8M$68.3M1.0%——
4 qtrssince 2020-Q2
Increased
67

GROWGENERATION CORP

1.3M$65M1.0%$9.04+449.52%
4 qtrssince 2020-Q2
Decreased
0
VALEVALE
ADR

VALE S A

3.7M$64.5M1.0%$10.190.00%
1 qtr
New
58
GTLSGTLSDelisted

<![CDATA[CHART INDUSTRIES INC]]>

433,759$61.7M0.9%——
6 qtrssince 2019-Q4
Increased
43

ADAPTHEALTH CORP

1.7M$60.7M0.9%$19.79+38.52%
5 qtrssince 2020-Q1
Increased
43

CALIX INC

1.7M$59M0.9%$27.13+22.83%
3 qtrssince 2020-Q3
Increased
47

MAGNITE INC

1.4M$58.8M0.9%$30.71+35.49%
2 qtrssince 2020-Q4
Decreased
0
$6.8B
AUM
435
Positions
Q1 2021
Filing
HI score · 1.5/5
Quarterly 13F Value Change
+22%Q4'19$3.8B-20%Q1'20$3B+37%Q2'20$4.1B+18%Q3'20$4.9B+27%Q4'20$6.2B+10%Q1'21$6.8B
Activity profile
$ moved · Q1'21
New29%Increased26%Decreased23%Exited21%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.8 quarters
<1Q25%1-4Q27%1-2Y24%2Y+24%

DRIEHAUS CAPITAL MANAGEMENT LLC manages $6.8B across 435 positions as of Q1 2021. Top holdings: TSM (5.2%), BABA (2.1%), HDB (1.7%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.

Q1 2021 Summary

Active quarter - 141 new positions, 119 exits, 152 increased. Top move: RLAY (INCREASED, conviction 76). Portfolio: $6.8B across 435 positions.

Top holdings by portfolio weight

Total AUM$7B
TSM5.17%
BABA2.11%
HDB1.67%
IBN1.44%
EPAM1.39%
SWTX1.37%
V1.32%
RLAY1.30%
NTRA1.16%
BIDU1.13%
Other1.11%

Portfolio allocation by GICS sector

Sectors11
Technology22.23%
Unknown18.57%
Consumer Cyclical14.95%
Healthcare13.97%
Financial Services9.14%
Industrials8.57%
Communication Services4.20%
Basic Materials3.32%
Consumer Defensive2.55%
Energy1.68%
Other0.83%

Behavioral investing profile

Checking access…
Diversified Scout- primarily Technology, Unknown, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L47
Conviction38
Concentration25
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
EWTXEWTXEDGEWISE THERAPEUTICS INC
Q2 2025 → Q2 2026+3.4M shares+$161.9M
5Q
IMAXIMAXIMAX CORP
Q2 2025 → Q2 2026+1.9M shares+$82.1M
4Q
IMNMIMNMIMMUNOME INC
Q3 2025 → Q2 2026+4.1M shares+$90M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used